EUVIMEDEUVIMED entdecken
Crossref

Overburden of rare ALMS1 deleterious variants in Chinese early‐onset type 2 diabetes with severe insulin resistance

Simin Zhang, Siqian Gong, Meng Li iD, Xiaoling Cai, Wei Liu, Yingying Lou, Yumin Ma, Xiuying Zhang, Qian Ren, Yu Zhu, Jing Wu, Lingli Zhou und 4 weitere

Diabetes/Metabolism Research and Reviews · 2024

DOI: 10.1002/dmrr.3788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2024. Verfasst von Simin Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Prediabetic State, Alstrom Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission Funding, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Alström syndrome (AS) is a rare recessive disorder characterised by diabetes, obesity, insulin resistance (IR), and visual and hearing impairments. Mutations in the ALMS1 gene have been identified as the causative agents of AS. This study aimed to explore the relationship between rare ALMS1 variants and clinical features in Chinese patients with early‐onset type 2 diabetes (age at diagnosis ≤40 years; EOD). Materials and Methods ALMS1 gene sequencing was performed in 611 Chinese individuals with EOD, 36 with postprandial hyperinsulinemia, and 47 with pre‐diabetes and fasting IR. In‐silico prediction algorithm and the American College of Medical Genetics Guidelines (ACMG) were used to evaluate the deleteriousness and pathogenicity of the variants.

Results

Sixty‐two rare ALMS1 variants (frequency

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2Prediabetic StateAlstrom SyndromeHyperinsulinismHumansAdultC-PeptideCell Cycle ProteinsObesityMutationChina

Stichwörter der Autor:innen

Alström syndromeearly onset diabetesinsulin resistancenext generation sequencingtype 2 diabetes

Substanzen

C-PeptideCell Cycle ProteinsALMS1 protein, human

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
  • Department of Endocrinology, Beijing Friendship Hospital Pinggu Campus, Capital Medical University, Beijing, China.

ORCID-Profile: Meng Li

Förderung

  • Beijing Municipal Science and Technology Commission Funding
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, S., Gong, S., Li, M., Cai, X., Liu, W., Lou, Y., Ma, Y., Zhang, X., Ren, Q., Zhu, Y., Wu, J., Zhou, L., Li, Y., Zhou, X., Han, X., & Ji, L. (2024). Overburden of rare ALMS1 deleterious variants in Chinese early‐onset type 2 diabetes with severe insulin resistance. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3788

Vancouver

Zhang S, Gong S, Li M, Cai X, Liu W, Lou Y, et al. Overburden of rare ALMS1 deleterious variants in Chinese early‐onset type 2 diabetes with severe insulin resistance. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3788

BibTeX
@article{Zhang2024,
  author = {Zhang, Simin and Gong, Siqian and Li, Meng and Cai, Xiaoling and Liu, Wei and Lou, Yingying and Ma, Yumin and Zhang, Xiuying and Ren, Qian and Zhu, Yu and Wu, Jing and Zhou, Lingli and Li, Yufeng and Zhou, Xianghai and Han, Xueyao and Ji, Linong},
  title = {Overburden of rare ALMS1 deleterious variants in Chinese early‐onset type 2 diabetes with severe insulin resistance},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  doi = {10.1002/dmrr.3788}
}
Kostenlos starten →